price
GM
NASDAQ · GMAB
Genmab A/S
Healthcare · Biotechnology
$37.07
Up+$1.02 (+2.83%)
Updated Oct 10, 2026, 9:03 PM
SID Score
7.5/10
Composite research score
Smart Money
51/100
Neutral
- Market cap
- 19.89B
- P/E ratio
- 14.56
- Dividend yield
- 0.00%
- 52-week range
- $23.62 – $40.17
- Volume
- 2.33M
- Avg. volume
- 2.09M
Price performance · GMAB
GMAB price history
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 9, 2026
GMAB closed at $37.07 after 21 trading sessions, up 14.17% for the selected period.
- Last close
- $37.07
- Period change
- +14.17%
- Period low
- $32.47
- Period high
- $38.48
Daily close
View OHLC price history
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 9, 2026 | $36.55 | $37.15 | $36.33 | $37.07 | 2.33M |
| Oct 8, 2026 | $36.175 | $36.285 | $35.09 | $36.05 | 4.3M |
| Oct 7, 2026 | $37.28 | $37.87 | $36.27 | $36.65 | 4.25M |
| Oct 6, 2026 | $39.11 | $39.15 | $37.07 | $37.80 | 6.6M |
| Oct 5, 2026 | $35.09 | $40.17 | $35.02 | $38.48 | 12.4M |
| Oct 2, 2026 | $34.39 | $35.02 | $33.725 | $34.75 | 5.44M |
| Oct 1, 2026 | $35.25 | $35.80 | $34.515 | $34.55 | 6.38M |
| Sep 30, 2026 | $35.72 | $35.905 | $35.37 | $35.675 | 5.15M |
| Sep 29, 2026 | $34.94 | $35.64 | $34.89 | $35.57 | 3.83M |
| Sep 28, 2026 | $34.76 | $35.70 | $34.63 | $35.36 | 2.79M |
| Sep 25, 2026 | $34.95 | $35.47 | $34.70 | $35.32 | 3.58M |
| Sep 24, 2026 | $34.69 | $35.03 | $34.36 | $34.83 | 2.51M |
| Sep 23, 2026 | $35.39 | $35.66 | $34.605 | $34.75 | 2.51M |
| Sep 22, 2026 | $34.46 | $35.295 | $34.37 | $35.22 | 2.3M |
| Sep 21, 2026 | $34.70 | $34.865 | $34.36 | $34.69 | 1.58M |
| Sep 18, 2026 | $34.92 | $35.15 | $34.715 | $34.74 | 2.71M |
| Sep 17, 2026 | $34.28 | $34.77 | $34.22 | $34.535 | 2.7M |
| Sep 16, 2026 | $34.36 | $34.63 | $34.05 | $34.40 | 2.89M |
| Sep 15, 2026 | $32.34 | $34.185 | $32.34 | $34.15 | 3.09M |
| Sep 14, 2026 | $32.79 | $32.96 | $32.52 | $32.65 | 1.41M |
| Sep 11, 2026 | $32.45 | $32.70 | $32.27 | $32.47 | 1.39M |
Latest GMAB news
The latest Smart Investors Daily articles mentioning GMAB.
Stock researchResearch & News · SEC Filings
Company
Market Activity
Research & News
Loading stock research…